Paloma Partners’s Transmedics TMDX Stock Holding History

Paloma Partners’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,130	Closed	-$334K	–	1015
2024 Q3	$334K	Buy	+2,130	New	+$328K	0.01%	762

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Paloma Partners's TMDX Position: Q4 2024 in Review

Paloma Partners sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 2,130 shares — an estimated $334K sold.

Paloma Partners first reported a position in TMDX in Q3 2024 and held it in 1 quarter. The position peaked at $334K in Q3 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

Paloma Partners reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
Paloma Partners sold 2,130 Transmedics shares in Q4 2024, an estimated $334K.
Paloma Partners first reported a position in Transmedics in Q3 2024 and held it in 1 quarter.
Paloma Partners's Transmedics position peaked at $334K in Q3 2024.
315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.